Who’s In Charge of Your Trial??This webinar on March 19th will highlight the critical need for a hands-on Clinical Operations lead to mitigate risks and optimize execution. ?? Secure your spot today: https://lnkd.in/etKcTAKC ??? Key Learning Objectives: ? Understand the critical role of sponsor-side Clinical Operations leadership in driving trial success ? Identify the risks of delegating too much responsibility to CROs and how to mitigate them ? Learn strategies for creating an effective collaboration between sponsor and outsourcing teams ? Explore real-world examples where strong Clin Ops leadership made the different in complex trials
Clinical Leader
制药业
Erie，Pennsylvania 16,498 位关注者
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
关于我们
The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – clinical research & trials – and the professionals who make their living there. The Clinical Leader community is not made up of generalists. They’re specialists, like us. We deliver in-depth content from authoritative authors and sources because that’s what our community demands. Our editors connect with and interview top clinical executives from pharmaceutical and biotech companies who share best practices, challenges faced and overcome, clinical trends, partnering strategies, and experiences implementing new technologies. Additionally, our Clinical Leader Live series of live events provides an interactive forum where sponsor companies talk about some of today's biggest challenges when managing clinical trials. Even better, the audience gets to ask questions during the presentation.
- 网站
-
https://www.clinicalleader.com/
Clinical Leader的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Erie，Pennsylvania
- 创立
- 1995
- 领域
- Clinical Trials和CRO
动态
-
LaShell Robinson, head of global feasibility and trial equity at Takeda shared with Chief Editor Dan Schell how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics. https://lnkd.in/eyTMjNGQ
-
Clinical Leader Live ??? Speaker Spotlight: Devora Henderson, a seasoned Clinical Research Professional with over 20 years of experience, co-founded and scaled Centex Studies to an industry leader before its acquisition. She now mentors future professionals and leads a new research site network, Elevate Clinical Research. Watch Devora and other industry experts discuss what makes a good site-sponsor partnership and the responsibilities of each partner during our virtual event on March 27th: https://lnkd.in/e8pqBS3B
-
-
Dr. Charles Bridges, a leading cardiac surgeon, identifies the contributing factors to cardiac care obstacles and the adverse effects of “Cardiology Deserts”. https://lnkd.in/efJfCFMS Source:?Biorasi
-
Introducing Rave Lite! Join us TOMORROW (3/13) to discover how Medidata Solutions’ EDC platform can make your studies more efficient and affordable: https://lnkd.in/eqRfBSG5 In this webinar, Wayne Walker will discuss: ?? How Rave Lite reduces the cost and complexity of a clinical trial ?? The efficiencies gained in trial planning, execution, and oversight ?? Why this innovation is a game-changer for sponsors and CROs
-
-
WEBINAR: Join us on March 19th to learn why it's critical to have a hands-on Clinical Operations lead to mitigate risks, and optimize execution. Our expert panel will discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can establish a proactive, transparent, communicative dynamic that drives informed decision-making, enhances efficiency, and ultimately ensures trial success. ?? Reserve your spot today: https://lnkd.in/egpGGax7 ??? Speakers: Sara McCradden, Director of Clinical Operations, inSeption Group Steven Zelenkofske, Principal Consultant/Board Director/CSO, SLZ Consulting LLC/Dinaqor AG and Cadrenal Therapeutics/Dinaqor AG Lauren Glenn, Vice President of Clinical Operations, Spur Therapeutics
-
-
PDS Biotechnology CMO Kirk Shepard reveals his team’s interactions with the FDA as it sought to begin its Phase 3 trial for the treatment of HPV-positive recurrent and/or metastatic head and neck squamous cell carcinoma. https://lnkd.in/ezfiXAMJ
-
In this week's issue we'll explore: ? The FDA's Draft Guidance On The Use Of AI To Support Regulatory Decision-Making For Drug And Biological Products ? Diversity Data In The US: Understanding The FDA's Push For More Representation In Clinical Trials ? "Black Box" Thinking For Patient Recruitment ? Some Top Concerns When Implementing AI In Clinical Trials ? How Genetic Testing Can Help Rare Disease Patient Recruitment And More! Susan Shockey, Clarkston Consulting | Miranda McLaren, PCM TRIALS - Quality Mobile Research | Ross Jackson | Elena Sinclair ?? | Jolan Walter, University of South Florida Health and Johns Hopkins All Children's Hospital | IQVIA | Joseph Pategou | Medidata Solutions | Jessica Cordes, Clinical Excellence GmbH | Biorasi
-
On #InternationalWomensDay, it's important to acknowledge that despite progress to include women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek, MBA explains why the fight for inclusion isn't over. https://lnkd.in/e3FS-gjm
-
In this article, ActiGraph introduces an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization: https://lnkd.in/enqVEmWS